Free Trial

UniSuper Management Pty Ltd Trims Stock Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Aspen Aerogels logo with Construction background
Remove Ads

UniSuper Management Pty Ltd cut its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 11.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 848,287 shares of the construction company's stock after selling 107,100 shares during the period. UniSuper Management Pty Ltd owned about 1.03% of Aspen Aerogels worth $10,078,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. AlphaQuest LLC raised its stake in shares of Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after buying an additional 3,998 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in Aspen Aerogels during the fourth quarter worth about $164,000. Journey Strategic Wealth LLC purchased a new position in Aspen Aerogels during the fourth quarter valued at approximately $178,000. Ballentine Partners LLC boosted its position in Aspen Aerogels by 19.2% in the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after purchasing an additional 2,565 shares in the last quarter. Finally, Quest Partners LLC grew its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock worth $205,000 after purchasing an additional 5,361 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. B. Riley lowered their price target on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research report on Wednesday, February 19th. Barclays decreased their target price on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 19th. Seaport Res Ptn cut shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Craig Hallum reduced their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Finally, StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $19.11.

Remove Ads

Check Out Our Latest Report on Aspen Aerogels

Aspen Aerogels Price Performance

ASPN traded down $0.02 on Tuesday, reaching $6.38. 301,155 shares of the company's stock were exchanged, compared to its average volume of 1,831,842. Aspen Aerogels, Inc. has a twelve month low of $6.23 and a twelve month high of $33.15. The stock has a market cap of $523.42 million, a PE ratio of 39.85 and a beta of 2.28. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The stock's fifty day moving average price is $8.92 and its 200-day moving average price is $14.52.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Sell-side analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads